E‐cigarette or vaping product use‐associated lung injury (EVALI) features and recognition in the emergency department

Since August 2019, the pulmonary disease termed e‐cigarette or vaping product‐use associated lung injury (EVALI), has resulted in 2758 hospitalizations and 64 deaths in the United States. EVALI is considered in patients who have vaped or dabbed within 90 days of symptom onset, and have abnormal lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldy, Kim, Cao, Dazhe James, Weaver, Mary Madison, Rao, Devika, Feng, Sing‐Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593457/
https://www.ncbi.nlm.nih.gov/pubmed/33145562
http://dx.doi.org/10.1002/emp2.12112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593457/
https://www.ncbi.nlm.nih.gov/pubmed/33145562
http://dx.doi.org/10.1002/emp2.12112

Ejemplares similares